MECHANISMS OF DISEASE Graves' Ophthalmopathy

被引：1067
作者：
Bahn, Rebecca S. [1 ]
机构：
[1] Mayo Clin, Div Endocrinol Diabet Metab & Nutr, Rochester, MN 55905 USA
来源：
NEW ENGLAND JOURNAL OF MEDICINE | 2010年 / 362卷 / 08期
关键词：
THYROID-ASSOCIATED OPHTHALMOPATHY; HUMAN ORBITAL FIBROBLASTS; THYROTROPIN RECEPTOR EXPRESSION; FACTOR-I RECEPTOR; T-CELL-ACTIVATION; RHEUMATOID-ARTHRITIS; ADIPOSE-TISSUE; PREADIPOCYTE FIBROBLASTS; CONNECTIVE-TISSUE; GLYCOSAMINOGLYCAN PRODUCTION;
D O I：
10.1056/NEJMra0905750
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
This article reviews the mechanisms that lead to the development of Graves' ophthalmopathy. A central feature in its development is autoimmunity that involves not only T cells, B cells, and macrophages but also fibroblasts and adipose tissue within the orbit. Intraorbital cytokine-mediated inflammation also has a prominent role. These recent findings suggest new ways of treating this debilitating disease. Copyright © 2010 Massachusetts Medical Society.
引用
收藏
页码：726 / 738
页数：13
相关论文
共 122 条
  • [41] 15-DEOXY-DELTA(12,14)-PROSTAGLANDIN J(2) IS A LIGAND FOR THE ADIPOCYTE DETERMINATION FACTOR PPAR-GAMMA
    FORMAN, BM
    TONTONOZ, P
    CHEN, J
    BRUN, RP
    SPIEGELMAN, BM
    EVANS, RM
    [J]. CELL, 1995, 83 (05) : 803 - 812
  • [42] Association of thyrotrophin receptor antibodies with the clinical features of Graves' ophthalmopathy
    Gerding, MN
    van der Meer, JWC
    Broenink, M
    Bakker, O
    Wiersinga, WM
    Prummel, MF
    [J]. CLINICAL ENDOCRINOLOGY, 2000, 52 (03) : 267 - 271
  • [43] GRAVES R., 1835, LONDON MED SURG J, V7, P516
  • [44] The role of CD40 ligand in costimulation and T-cell activation
    Grewal, IS
    Flavell, RA
    [J]. IMMUNOLOGICAL REVIEWS, 1996, 153 : 85 - 106
  • [45] DETECTION OF TSH RECEPTOR RNA IN CULTURED FIBROBLASTS FROM PATIENTS WITH GRAVES OPHTHALMOPATHY AND PRETIBIAL DERMOPATHY
    HEUFELDER, AE
    DUTTON, CM
    SARKAR, G
    DONOVAN, KA
    BAHN, RS
    [J]. THYROID, 1993, 3 (04) : 297 - 300
  • [46] Cytokine profiles in eye muscle tissue and orbital fat tissue from patients with thyroid-associated ophthalmopathy
    Hiromatsu, Y
    Yang, D
    Bednarczuk, T
    Miyake, I
    Nonaka, K
    Inoue, Y
    [J]. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2000, 85 (03) : 1194 - 1199
  • [47] Treatment of systemic lupus erythematosus by inhibition of T cell costimulation with anti-CD154 - A randomized, double-blind, placebo-controlled trial
    Kalunian, KC
    Davis, JC
    Merrill, JT
    Totoritis, MQ
    Wofsy, D
    [J]. ARTHRITIS AND RHEUMATISM, 2002, 46 (12): : 3251 - 3258
  • [48] Insulin needs after CD3-antibody therapy in new-onset type 1 diabetes
    Keymeulen, B
    Vandemeulebroucke, E
    Ziegler, AG
    Mathieu, C
    Kaufman, L
    Hale, G
    Gorus, F
    Goldman, M
    Walter, M
    Candon, S
    Schandene, L
    Crenier, L
    De Block, C
    Seigneurin, JM
    De Pauw, P
    Pierard, D
    Weets, I
    Rebello, P
    Bird, P
    Berrie, E
    Frewin, M
    Waldmann, H
    Bach, JF
    Pipeleers, D
    Chatenoud, L
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2005, 352 (25) : 2598 - 2608
  • [49] Graves' ophthalmopathy in the absence of elevated free thyroxine and triiodothyronine levels: Prevalence, natural history, and thyrotropin receptor antibody levels
    Khoo, DH
    Eng, PH
    Ho, SC
    Tai, ES
    Morgenthaler, NG
    Seah, LL
    Fong, KS
    Chee, SP
    Choo, CT
    Aw, SE
    [J]. THYROID, 2000, 10 (12) : 1093 - 1100
  • [50] Evidence for Enhanced Thy-1 (CD90) Expression in Orbital Fibroblasts of Patients with Graves' Ophthalmopathy
    Khoo, Teck Kim
    Coenen, Michael J.
    Schiefer, A. Reagan
    Kumar, Seema
    Bahn, Rebecca S.
    [J]. THYROID, 2008, 18 (12) : 1291 - 1296
12345678910